2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Immunology
Concurrent

Advancing Sepsis Diagnostics: Implementing Novel Biomarkers and Technologies in the ED and ICU

Monday, March 23, 2026
1:30 PM - 2:15 PM Central Time
Location: W187

    Concurrent Session Moderator(s)

  • Kenneth Remy, MD, MSc, MSCI, FCCM

    Case Western Reserve University/University Hospitals Cleveland Medical Center, Ohio

    Disclosure(s): No relevant financial relationship(s) to disclose.

  • Vanessa Nomellini, MD, PhD

    University of Texas Southwestern Medical Center, Texas

    Disclosure(s): No relevant financial relationship(s) to disclose.

Sepsis remains a major cause of morbidity and mortality. Rapid, accurate diagnosis is critical for timely and effective treatment. Traditional sepsis diagnostics, reliant on clinical criteria and broad biomarkers such as lactate and procalcitonin, have significant limitations. Emerging technologies, including gene expression profiling, host-response biomarkers, and rapid cellular morphology assessment, offer promising advancements in early sepsis identification and risk stratification.

Learning Objectives:

  • Review the diagnostic capabilities of emerging sepsis biomarker technologies and their potential roles in clinical decision-making
  • Explore strategies for integrating these diagnostic tools into emergency departments and ICUs to enhance early sepsis detection and stratification
  • Discuss challenges of implementing these diagnostic tools given their absence from current sepsis guidelines, and propose solutions to bridge this gap

Presentations:

  • 1:35 PM - 1:50 PM Central Time
    The Science Behind Emerging Sepsis Biomarkers: What Do They Measure and Why Do They Matter?

    Scott Brakenridge, MD – University of Washington School of Medicine

  • 1:50 PM - 2:05 PM Central Time
    Implementing Novel Sepsis Diagnostics in the Emergency Department and ICU: Practical Considerations

    Jerry J. Zimmerman, MD, PhD, MCCM (he/him/his) – Seattle Children's Hospital